<?xml version="1.0" encoding="UTF-8"?>
<ref id="B77">
 <label>77.</label>
 <mixed-citation publication-type="other">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Bergin</surname>
    <given-names>C</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Philbin</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Gilvarry</surname>
    <given-names>P</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>O'connor</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>King</surname>
    <given-names>F</given-names>
   </name>
  </person-group>
  <article-title>Specific Antiviral Therapy in the Clinical Management of Acute Respiratory Infection with SARS-CoV-2 (COVID-19)</article-title>. 
  <ext-link ext-link-type="uri" xlink:href="https://www.hse.ie/eng/about/who/acute-hospitals-division/drugs-management-programme/guidelines/specific-antiviral-therapy-in-the-clinical-management-of-acute-respiratory-infection-with-sars-cov-2-covid-19.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">ww.hse.ie/eng/about/who/acute-hospitals-division/drugs-management-programme/guidelines/specific-antiviral-therapy-in-the-clinical-management-of-acute-respiratory-infection-with-sars-cov-2-covid-19.pdf</ext-link>
 </mixed-citation>
</ref>
